FOUNTAIN VALLEY, CALIFORNIA--(Marketwire - May 14, 2008) - Sutura, Inc. (“Sutura”) (OTCBB: SUTU), a California-based medical device company, announced today that Dr. Michael Mullen, lead clinician for interventional cardiology at Royal Brompton Hospital in London, performed two successful PFO closures using the newly released SuperStitch EL. Dr. Mullen is a member of Sutura’s Clinical Advisory Board, and is currently consultant cardiologist and Director of the Cath Lab at Royal Brompton, specializing in adult congenital interventional catheter laboratory procedures.
